189 related articles for article (PubMed ID: 20480551)
21. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
22. Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Clinch K; Crump DR; Evans GB; Hazleton KZ; Mason JM; Schramm VL; Tyler PC
Bioorg Med Chem; 2013 Sep; 21(17):5629-46. PubMed ID: 23810424
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of Plasmodium falciparum adenosine deaminase reveals a novel binding pocket for inosine.
Jaruwat A; Riangrungroj P; Ubonprasert S; Sae-Ueng U; Kuaprasert B; Yuthavong Y; Leartsakulpanich U; Chitnumsub P
Arch Biochem Biophys; 2019 May; 667():6-13. PubMed ID: 31002765
[TBL] [Abstract][Full Text] [Related]
24. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
[TBL] [Abstract][Full Text] [Related]
25. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
Sanfilippo O; Camici M; Tozzi MG; Turriani M; Faranda A; Ipata PL; Silvestrini R
Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
[TBL] [Abstract][Full Text] [Related]
27. Identification of a peptide derived from a Bothrops moojeni metalloprotease with in vitro inhibitory action on the Plasmodium falciparum purine nucleoside phosphorylase enzyme (PfPNP).
Martins GG; de Jesus Holanda R; Alfonso J; Gómez Garay AF; Dos Santos APA; de Lima AM; Francisco AF; Garcia Teles CB; Zanchi FB; Soares AM
Biochimie; 2019 Jul; 162():97-106. PubMed ID: 30978375
[TBL] [Abstract][Full Text] [Related]
28. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter.
Quashie NB; Ranford-Cartwright LC; de Koning HP
Malar J; 2010 Jan; 9():36. PubMed ID: 20113503
[TBL] [Abstract][Full Text] [Related]
29. Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases.
Keough DT; Skinner-Adams T; Jones MK; Ng AL; Brereton IM; Guddat LW; de Jersey J
J Med Chem; 2006 Dec; 49(25):7479-86. PubMed ID: 17149876
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Hocková D; Holý A; Masojídková M; Keough DT; de Jersey J; Guddat LW
Bioorg Med Chem; 2009 Sep; 17(17):6218-32. PubMed ID: 19666228
[TBL] [Abstract][Full Text] [Related]
31. Purine import into malaria parasites as a target for antimalarial drug development.
Frame IJ; Deniskin R; Arora A; Akabas MH
Ann N Y Acad Sci; 2015 Apr; 1342(1):19-28. PubMed ID: 25424653
[TBL] [Abstract][Full Text] [Related]
32. Purine metabolism in Echinococcus multilocularis.
Suchail S; Sarciron ME; Petavy AF
Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):633-7. PubMed ID: 9854810
[TBL] [Abstract][Full Text] [Related]
33. A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival.
Minnow YVT; Harijan RK; Schramm VL
J Biol Chem; 2021; 296():100342. PubMed ID: 33524395
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
Cheviet T; Lefebvre-Tournier I; Wein S; Peyrottes S
J Med Chem; 2019 Sep; 62(18):8365-8391. PubMed ID: 30964283
[TBL] [Abstract][Full Text] [Related]
35. Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.
Naguib FNM; Wilson CM; El Kouni MH
Int J Biochem Cell Biol; 2018 Dec; 105():115-122. PubMed ID: 30381242
[TBL] [Abstract][Full Text] [Related]
36. Development of a continuous assay for high throughput screening to identify inhibitors of the purine salvage pathway in Plasmodium falciparum.
Grube CD; Gill CP; Roy H
SLAS Discov; 2022 Mar; 27(2):114-120. PubMed ID: 35058189
[TBL] [Abstract][Full Text] [Related]
37. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
38. Transition states and inhibitors of the purine nucleoside phosphorylase family.
Taylor Ringia EA; Schramm VL
Curr Top Med Chem; 2005; 5(13):1237-58. PubMed ID: 16305529
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
40. Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Hazleton KZ; Ho MC; Cassera MB; Clinch K; Crump DR; Rosario I; Merino EF; Almo SC; Tyler PC; Schramm VL
Chem Biol; 2012 Jun; 19(6):721-30. PubMed ID: 22726686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
